News

Select Category
News & Insights
December 10, 2020

Covid-19 : la startup Aqemia sur les rangs pour trouver un médicament

La startup Aqemia, spécialisée dans la recherche de médicaments, adopte une approche différenciante en combinant intelligence artificielle et physique théorique. Un avantage repéré par le Français Sanofi, avec qui elle coopère afin de mettre au point un traitement contre le Covid-19.
News & Insights
December 10, 2020

Covid-19 : la startup Aqemia sur les rangs pour trouver un médicament

La startup Aqemia, spécialisée dans la recherche de médicaments, adopte une approche différenciante en combinant intelligence artificielle et physique théorique. Un avantage repéré par le Français Sanofi, avec qui elle coopère afin de mettre au point un traitement contre le Covid-19.
News & Insights
December 10, 2020

Maximilien Levesque ( Aqemia) : La start-up Aqemia reçoit le soutien de Sanofi pour sa recherche de médicaments contre le coronavirus

Maximilien Levesque (CEO and co-founder of Aqemia) discusses Aqemia's partnership with Sanofi to research treatments for COVID-19 on the show Tech&CO (BFM Business).
News & Insights
December 10, 2020

Maximilien Levesque ( Aqemia) : La start-up Aqemia reçoit le soutien de Sanofi pour sa recherche de médicaments contre le coronavirus

Maximilien Levesque (CEO and co-founder of Aqemia) discusses Aqemia's partnership with Sanofi to research treatments for COVID-19 on the show Tech&CO (BFM Business).
News & Insights
December 10, 2020

La start-up Aqemia reçoit le soutien de Sanofi pour sa recherche de médicaments contre le coronavirus

Maximilien Levesque, co-founder of Aqemia, discussed the support of Sanofi for his start-up's coronavirus drug research in the TV show "Tech & Co" presented by Sébastien Couasnon on BFM Business.
News & Insights
December 10, 2020

La start-up Aqemia reçoit le soutien de Sanofi pour sa recherche de médicaments contre le coronavirus

Maximilien Levesque, co-founder of Aqemia, discussed the support of Sanofi for his start-up's coronavirus drug research in the TV show "Tech & Co" presented by Sébastien Couasnon on BFM Business.
News & Insights
December 9, 2020

Press Release - Aqemia receives support and funding from Sanofi to apply its disruptive technology against COVID-19

Aqemia announces an agreement with the pharmaceutical company Sanofi to contribute to the discovery of effective treatments for COVID-19. As part of this agreement, Aqemia will apply its generative AI combined with its disruptive proprietary algorithms for affinity calculation between therapeutic targets and drug candidates.
News & Insights
December 9, 2020

Press Release - Aqemia receives support and funding from Sanofi to apply its disruptive technology against COVID-19

Aqemia announces an agreement with the pharmaceutical company Sanofi to contribute to the discovery of effective treatments for COVID-19. As part of this agreement, Aqemia will apply its generative AI combined with its disruptive proprietary algorithms for affinity calculation between therapeutic targets and drug candidates.
December 8, 2020

Santé numérique : ces startups deeptech qui transforment le secteur

Bpifrance publishes a mapping of Deeptech startups in Digital Health. Aqemia is featured as an example in the category: "services to big pharmas".
December 8, 2020

Santé numérique : ces startups deeptech qui transforment le secteur

Bpifrance publishes a mapping of Deeptech startups in Digital Health. Aqemia is featured as an example in the category: "services to big pharmas".